Angion Biomedica ANGN Stock
Angion Biomedica Price Chart
Angion Biomedica ANGN Financial and Trading Overview
| Angion Biomedica stock price | 1 USD |
| Previous Close | 1 USD |
| Open | 1.06 USD |
| Bid | 0 USD x 1100 |
| Ask | 0 USD x 1200 |
| Day's Range | 1 - 1 USD |
| 52 Week Range | 1 - 20.4 USD |
| Volume | 224.8K USD |
| Avg. Volume | 10.02K USD |
| Market Cap | 30.11M USD |
| Beta (5Y Monthly) | 0.598413 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ANGN Valuation Measures
| Enterprise Value | 1.19M USD |
| Trailing P/E | N/A |
| Forward P/E | -1.8867925 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 46.115925 |
| Price/Book (mrq) | 0.7593014 |
| Enterprise Value/Revenue | 1.825 |
| Enterprise Value/EBITDA | -0.058 |
Trading Information
Angion Biomedica Stock Price History
| Beta (5Y Monthly) | 0.598413 |
| 52-Week Change | -23.076% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 20.4 USD |
| 52 Week Low | 1 USD |
| 50-Day Moving Average | 7.17 USD |
| 200-Day Moving Average | 8.11 USD |
ANGN Share Statistics
| Avg. Volume (3 month) | 10.02K USD |
| Avg. Daily Volume (10-Days) | 29.25K USD |
| Shares Outstanding | 30.11M |
| Float | 20.9M |
| Short Ratio | 0.73 |
| % Held by Insiders | 33.02% |
| % Held by Institutions | 16.36% |
| Shares Short | 63.65K |
| Short % of Float | 0.25% |
| Short % of Shares Outstanding | 0.20% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -3148.23% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -20.88% |
| Return on Equity (ttm) | -54.46% |
Income Statement
| Revenue (ttm) | 653K USD |
| Revenue Per Share (ttm) | 0.02 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -15799000 USD |
| EBITDA | -20390000 USD |
| Net Income Avi to Common (ttm) | -29104000 USD |
| Diluted EPS (ttm) | -10.11 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 29.22M USD |
| Total Cash Per Share (mrq) | 0.97 USD |
| Total Debt (mrq) | 297K USD |
| Total Debt/Equity (mrq) | 0.75 USD |
| Current Ratio (mrq) | 20.003 |
| Book Value Per Share (mrq) | 1.317 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -30816000 USD |
| Levered Free Cash Flow (ttm) | -26601750 USD |
Profile of Angion Biomedica
| Country | United States |
| State | MA |
| City | Newton |
| Address | 7-57 Wells Avenue |
| ZIP | 11553 |
| Phone | 415-655-4899 |
| Website | https://www.angion.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 3 |
Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for chronic and progressive fibrotic diseases in the United States. The company develops ANG-3070, an oral tyrosine kinase receptor inhibitor for fibrotic diseases in kidney and lung. It also develops ROCK2 inhibitors for fibrotic diseases; CYP11B2, an inhibitor program for aldosterone-related diseases, including resistant hypertension, congestive heart failure, renal fibrosis, and hyperaldosteronism; and CYP26 for the degradation of retinoic acid. Angion Biomedica Corp. was incorporated in 1998 and is based in Uniondale, New York.
Q&A For Angion Biomedica Stock
What is a current ANGN stock price?
Angion Biomedica ANGN stock price today per share is 1 USD.
How to purchase Angion Biomedica stock?
You can buy ANGN shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Angion Biomedica?
The stock symbol or ticker of Angion Biomedica is ANGN.
Which industry does the Angion Biomedica company belong to?
The Angion Biomedica industry is Biotechnology.
How many shares does Angion Biomedica have in circulation?
The max supply of Angion Biomedica shares is 30.11M.
What is Angion Biomedica Price to Earnings Ratio (PE Ratio)?
Angion Biomedica PE Ratio is 0.00000000 now.
What was Angion Biomedica earnings per share over the trailing 12 months (TTM)?
Angion Biomedica EPS is 0 USD over the trailing 12 months.
Which sector does the Angion Biomedica company belong to?
The Angion Biomedica sector is Healthcare.
Angion Biomedica ANGN included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Select Market Com NQGS | 7876.03 USD — |
-1.61
|
— — | 7852.08 USD — | 7955.84 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}